<DOC>
	<DOCNO>NCT01161524</DOCNO>
	<brief_summary>This study design investigate short- long-term effect perampanel cognition , growth , development adolescent .</brief_summary>
	<brief_title>A Study With Open-label Extension Phase Evaluate Effect Perampanel ( E2007 ) Cognition , Growth , Safety , Tolerability , Pharmacokinetics Adolescents</brief_title>
	<detailed_description />
	<criteria>1 . Considered reliable willing available study duration able record seizures report adverse event ( AEs ) legal guardian caregiver record seizures report AEs 2 . Understand requirement Cognitive Drug Research ( CDR ) System test able perform test appropriately Visit 1 3 . Male female , 12 less 18 year age time consent/assent 4 . Have diagnosis epilepsy partialonset seizure without secondarily generalize seizures accord International League Against Epilepsy 's ( ILAE ) Classification Epileptic Seizures ( 1981 ) . 5 . Diagnosis establish least 6 month prior Visit 1 , clinical history electroencephalogram ( EEG ) consistent localizationrelated epilepsy ; normal interictal EEGs allow provide subject meet diagnosis criterion ( ie , clinical history ) 6 . Have brain imaging ( e.g. , magnetic resonance image [ MRI ] scan compute tomography [ CT ] ) within 5 year prior Visit 1 rule progressive cause epilepsy 7 . Must least 1 partialonset seizure 4 week prior Visit 1 despite stable regimen 1 3 concomitant antiepileptic drug ( AEDs ) 8 . Are currently treat stable dos 13 AEDs . Only 1 inducer AED ( either carbamazepine phenytoin ) maximum 3 AEDs allow 9 . Are stable dose concomitant AED ( ) least 4 week prior Visit 1 ; case new AED regimen initiate subject , dose must stable least 8 week prior Visit 1 10 . Female subject childbearing potential must negative serum human chorionic gonadotropin ( ? hCG ) Visit 1 negative urine pregnancy test prior randomization Visit 2 . Female subject period least 60 day follow administration last dose study medication commit consistent correct use medically acceptable method birth control ( e.g. , doublebarrier method [ condom + spermicide , condom + diaphragm spermicide ] ) . Abstinence consider acceptable method contraception case case basis upon prior approval Medical Monitor 11 . Have intelligence quotient ( IQ ) ? 70 , use Kaufman Brief Intelligence Test , second edition ( KBIT2 ) Extension Phase : Have complete schedule visit include Visit 8 Core Study Randomization Phase 1 . Have diagnosis primary generalized epilepsy seizures absence and/or myoclonic epilepsy 2 . Have current history pseudoseizures ( psychogenic nonepileptic seizure [ PNES ] ) within approximately 5 year prior Visit 1 3 . Have diagnosis LennoxGastaut syndrome 4 . Have seizure cluster individual seizure count 5 . Have history status epilepticus require hospitalization 12 month prior Visit 1 6 . Have unstable psychiatric diagnosis may confound investigator 's ability conduct study may prevent completion protocol specify test ( e.g. , significant suicide risk , include suicidal behavior ideation 6 month prior Visit 1 , current psychotic disorder , acute mania ) 7 . Have concomitant illnesses/comorbidities ( e.g. , autism , attention deficit hyperactivity disorder [ ADHD ] ) Visit 1 could severely affect cognitive function course study 8 . Have previously participate clinical trial involve perampanel 9 . Have chronically routinely use benzodiazepine discontinue use least 4 week prior Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>